Newsy's Latest Health News

The US government has partnered with AstraZeneca, committing up to $1.2 billion to expedite the development of a COVID-19 vaccine, aiming for 300 million doses by October and a phase three trial with 30,000 volunteers. HHS Secretary Alex Azar highlights this as a milestone for vaccine availability by 2021. Concurrently, the FDA is tightening regulations on COVID-19 antibody tests, approving only 12 companies while removing others from the market for not meeting application requirements.

What is the main goal of the US government's partnership with AstraZeneca?

• To conduct research on COVID-19 variants

• To speed up the development of a COVID-19 vaccine

• To develop a new type of COVID-19 treatment

• To create a global distribution network for vaccines

How many doses of the COVID-19 vaccine does the US aim to secure through its deal with AstraZeneca?

• 400,000,000 doses

• 300,000,000 doses

• 200,000,000 doses

• 100,000,000 doses

By when does the US Department of Health and Human Services plan to make the COVID-19 vaccine available?

• By 2022

• By the end of 2020

• By mid-2021

• By 2021

What action has the FDA taken regarding coronavirus antibody tests?

• Allowed free distribution of tests

• Banned all antibody tests

• Published a list of approved test makers

• Approved all available tests

How many companies have been approved by the FDA to distribute antibody tests?

• 15 companies

• 12 companies

• 10 companies

• 20 companies